1. Evaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body Weight. (20th March 2017) Authors: Hutmacher, MM; Papp, K; Krishnaswami, S; Ito, K; Tan, H; Wolk, R; Valdez, H; Mebus, C; Rottinghaus, ST; Gupta, P Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 6:Number 5(2017) Page Start: 322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗